KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Share-based Compensation (IS)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

BioNTech SE (BNTX) Interest & Investment Income (2018 - 2025)

BioNTech SE's Interest & Investment Income history spans 8 years, with the latest figure at $115.9 million for Q4 2025.

  • On a quarterly basis, Interest & Investment Income fell 34.32% to $115.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $477.4 million, a 34.09% decrease, with the full-year FY2025 number at $478.9 million, down 32.5% from a year prior.
  • Interest & Investment Income hit $115.9 million in Q4 2025 for BioNTech SE, up from $113.2 million in the prior quarter.
  • Over the last five years, Interest & Investment Income for BNTX hit a ceiling of $305.4 million in Q1 2022 and a floor of -$1.4 million in Q3 2021.
  • Historically, Interest & Investment Income has averaged $118.9 million across 5 years, with a median of $121.3 million in 2022.
  • Biggest five-year swings in Interest & Investment Income: surged 3127884903.33% in 2021 and later tumbled 71.07% in 2023.
  • Tracing BNTX's Interest & Investment Income over 5 years: stood at $18.6 million in 2021, then surged by 112.29% to $39.6 million in 2022, then soared by 340.86% to $174.5 million in 2023, then grew by 1.15% to $176.5 million in 2024, then tumbled by 34.32% to $115.9 million in 2025.
  • Business Quant data shows Interest & Investment Income for BNTX at $115.9 million in Q4 2025, $113.2 million in Q3 2025, and $119.3 million in Q2 2025.